Equifax, Inc. EFX

148.11 (0.69) (0.46%) as of 25 Sep
Market cap
$17.5B
P/E
25.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

13.33% 13.99% 14.61% 14.53%
ROA 5.45% 5.59% 5.87% 5.79%
ROIC 7.79% 8.05% 8.50% 8.68%
Return on Tangible Assets 47.17% 65.43% 72.36% 78.11%
Average Days of Receivables 62.33 60.85 62.29 62.53
Free Cash Flow per Share 8.12 9.21 9.49 9.33
Free Cash Flow 999.40 1,134.30 1,139.10 1,105.00
Capital Expenditures (470.30) (481.40) (494.60) (507.40)
Piotroski F-Score 7.00 7.00 7.00 6.00
Other line items
Cash ROIC 15.98% 18.24% 18.56% 18.69%
Accounts Receivable Turnover 6.04 6.17 6.01 6.01
Accounts Payable Turnover 16.82 15.35 16.67 19.18
Inventory Turnover 0.00 0.00 0.00 0.00
Average Days of Payables 21.93 28.48 20.98 16.13
Days of Inventory on Hand 0.00 0.00 0.00 0.00
Tax Rate (0.25) (0.26) (0.26) (0.26)
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 25.88% 26.57% 26.27% 26.20%
Share Based Compensation of Revenue 1.24% 1.29% 1.40% 1.43%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 2.23 2.45 2.34 2.33
Depreciation/Fixed assets 0.37 0.38 0.38 0.39
Capex/Depreciation (0.66) (0.66) (0.67) (0.68)
Revenue per Share 48.28 49.31 52.35 54.43
Operating CF per Share 11.94 13.11 13.61 13.62
Capex per Share (3.82) (3.91) (4.12) (4.29)
Capex to Sales 0.08 0.08 0.08 0.08
Net Profit Margin 11.08% 10.87% 11.12% 10.73%

Fold the line items

Columns are period end dates